Amendment: SEC Form F-1/A filed by NewGenIvf Group Limited
$NIVF
Misc Health and Biotechnology Services
Health Care
Unavailable
Unavailable
Save time and jump to the most important pieces.
BANGKOK, May 01, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company"), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced that it is implementing a reverse stock split of all of the Company's issued and unissued shares at an exchange ratio of one (1) share for ten (10) shares (the "Reverse Stock Split"). The Company's Class A Ordinary Shares will begin trading on the Nasdaq Global Market on a post-Reverse Stock Split basis under the current ticker symbol "NIVF" at the commencement of trading on May 5, 2025, under the new CUSIP number G0544E121. The Reverse Stock S
BANGKOK, April 22, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company"), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2024 with the Securities and Exchange Commission on April 22, 2025 Eastern Time. The annual report can be accessed on the Company's investor relations website at https://investors.newgenivf.com. Mr. Siu Wing Fung Alfred, Founder, Chairman, and CEO of NewGen, commented, "With $2.48 million cash with bank and a cash deposit of $1 million with a trading plat
BANGKOK, April 03, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company"), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced that it has secured $5.2 million in strategic funding through two separate arrangements with an investor ("the investor"), with the potential to raise a total of up to $30.8 million through the arrangements. These funding arrangements will provide the necessary capital for NewGen to execute on key growth initiatives, including the establishment of a state-of-the-art fertility clinic in Dubai, United Arab Emirates. On April 2, 2025, the Compa
F-1/A - NewGenIvf Group Ltd (0001981662) (Filer)
6-K - NewGenIvf Group Ltd (0001981662) (Filer)
20-F - NewGenIvf Group Ltd (0001981662) (Filer)
Company Granted Request to Continue its Listing on NasdaqAppoints Thorain Ko to Lead Business Development Initiatives BANGKOK, Feb. 20, 2025 (GLOBE NEWSWIRE) -- NewGenIvf Group Limited (NASDAQ:NIVF) ("NewGen" or the "Company"), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced that the Nasdaq Hearings Panel (the "Panel") has granted the Company's request for continued listing on The Nasdaq Stock Market, subject to specific conditions. Additionally, the Company announced the appointment of Mr. Thorain Ko as Business Development Director to drive its expansion initiatives. Nasdaq Listing UpdateThe Pane
SC 13G - NewGenIvf Group Ltd (0001981662) (Subject)
SC 13G - NewGenIvf Group Ltd (0001981662) (Subject)
SC 13G - NewGenIvf Group Ltd (0001981662) (Subject)
3 - NewGenIvf Group Ltd (0001981662) (Issuer)